January 18, 2017 / 1:22 PM / 7 months ago

BRIEF-FDA grants fast track designation for aTyr's Resolaris

Jan 18 (Reuters) - Atyr Pharma Inc :

* Fda grants fast track designation for aTyr's Resolaris to treat limb girdle muscular dystrophy 2b and removes partial clinical hold for Resolaris

* Atyr Pharma Inc says in addition, FDA removed its partial clinical hold on a dosing ceiling for resolaris in clinical trials Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below